HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a novel type of chain-terminator Gal beta 1-6Gal beta 1-4)GlcNAc in an oligosaccharide related to N-glycosylated protein glycans isolated from GM1 the urine of patients with gangliosidosis.

Abstract
Two new oligosaccharides were isolated from the urine of a patient with GM1 gangliosidosis. Final purification of the oligosaccharides was accomplished by capillary supercritical fluid chromatography. Structural analysis was by chemical analysis, chemical-ionization mass spectrometry and 400-MHz 1H-NMR spectroscopy, leading to two primary structures. The first is derived from a classical triantennary N-acetyllactosamine-type glycan: Gal beta 1-4GlcNAc beta 1-4(Gal beta 1-4GlcNAc beta 1-2)Man alpha 1-3Man beta 1-4GlcNAc. The second is unusual with a terminal disaccharide Gal beta 1-6Gal, which had not yet been described for glycans of the N-acetyllactosamine type: Gal beta 1-6Gal beta 1-4GlcNAc beta 1-2Man alpha 1-6Man beta 1-4GlcNAc.
AuthorsJ C Michalski, J Lemoine, J M Wieruszeski, B Fournet, J Montreuil, G Strecker
JournalEuropean journal of biochemistry (Eur J Biochem) Vol. 198 Issue 2 Pg. 521-6 (Jun 01 1991) ISSN: 0014-2956 [Print] England
PMID1904026 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligosaccharides
  • Proteoglycans
  • G(M1) Ganglioside
Topics
  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Chromatography, Paper
  • G(M1) Ganglioside (isolation & purification, urine)
  • Gangliosidoses (urine)
  • Glycosylation
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Molecular Sequence Data
  • Oligosaccharides (isolation & purification, urine)
  • Proteoglycans (isolation & purification, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: